LifeVantage Expands Global Reach with International Launch of the MB System™
Following the highly successful launch in U.S. market, LifeVantage begins taking its groundbreaking MB System™ internationally
SALT LAKE CITY, March 17, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets. This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., largely driven by the system's success, and clinical data on that formula reinforcing its effectiveness in supporting GLP-1 production.
The MB System™, as the product is known internationally, launched on March 15 for both LifeVantage Consultants and Customers in Japan. On the same date, it became available exclusively to Consultants in Australia, New Zealand, Europe, the UK, Mexico, and Thailand. Customers in these regions gain access starting April 25.
The MB System™ is designed to naturally activate the body's own GLP-1 production, providing a range of long-term health benefits that expand to weight management and beyond.*
'Consumers worldwide are seeking sustainable health solutions that go beyond short-term, unsustainable weight management,' said Steve Fife, President and CEO of LifeVantage. 'The MB System™ works harmoniously with the body, empowering individuals to naturally enhance their metabolic health in alignment with their lifestyle and wellness objectives.'*
Meeting a Growing Global DemandInterest in GLP-1 and metabolic health is rising worldwide. The global GLP-1 pharmaceutical market alone was valued at $53.46 billion in 2024 and is projected to grow at a CAGR of 17.5% from 2025 to 2030, reaching approximately $156.71 billion by 2030**.
In many regions, the focus is on holistic wellness, metabolic balance, and overall vitality in addition to weight management. The MB System™ aligns with this perspective by supporting the body's natural ability to regulate metabolism, gut health, and hormone function—key factors in long-term health.*
'The research that is emerging on all the positive health benefits of the GLP-1 hormone continues to excite us,' said Lisa Barnes, Vice President of Research & Development and Regulatory at LifeVantage. 'From gut and digestive benefits, heart and cardiovascular benefits, and the health of other critical organs like the kidneys and liver, GLP-1 is a hormone essential for our longevity and vitality. We are so proud of this product and the clinically shown efficacy in activating the body's own production of the hormone.'
Looking Ahead: Future Market ExpansionsEarly this summer, LifeVantage will launch the MB System™ in the Philippines and Taiwan, followed by Canada later in the year, completing the global rollout and reinforcing our commitment to providing natural Activation solutions worldwide.
For more information, visit LifeVantage.com.
About LifeVantage CorporationLifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.*
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.**https://www.grandviewresearch.com/industry-analysis/glp-1-receptor-agonist-market
Public Relations Contact: Jennifer Rumble, CerconeBrownCompany(704) 923-6378 lifevantage@cerconebrown.com
Investor Relations Contact: Reed Anderson, ICR (646) 277-1260 reed.anderson@icrinc.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Why Casey's General Stores Stock Skyrocketed This Week
Casey's General Stores is quietly the fifth-largest pizza chain in the United States. It continues to grow its geographic footprint beyond the Midwest, and is now in 20 states. Leaning on its ability to make shrewd acquisitions, Casey's growth story could still be in its early chapters. 10 stocks we like better than Casey's General Stores › Shares of Midwestern pizza and convenience store chain Casey's General Stores (NASDAQ: CASY) were 13% higher this week as of 12:30 p.m. ET Thursday, according to data provided by S&P Global Market Intelligence. Reporting fourth-quarter earnings, Casey's delivered earnings before interest, taxes, depreciation, and amortization (EBITDA) and earnings per share growth of 20% and 12%, surpassing analysts' expectations. This booming profitability, paired with management's announcement of a 14% dividend increase, sent Casey's shares skyward. Casey's General Stores operates approximately 2,900 locations, primarily located in small towns across the Midwest. As it expanded beyond its roots in Iowa to its current footprint of 20 states, the company has become a 258-bagger since 1990. Despite this incredible run, I recently wrote that Casey's is still an excellent long-term buy -- despite nearing all-time highs. And again, I'd argue it still looks pretty promising even after this week's run-up. Growing its store count by 9% in 2025, management's expansion plans show no signs of slowing. Powered by its mergers and acquisitions team, Casey's has been expanding into new states, like Texas, Tennessee, and Florida. The reason this M&A model works so well is that Casey's typically focuses on buying convenience stores without a strong food presence. Then it adds a Casey's kitchen, bringing in its beloved pizza-making and prepared food capabilities to these new locations, boosting profitability and generating a strong return on its investment. However, even with its recent success, the company's valuation remains reasonable at 17 times cash from operations (CFO). For example, whereas Casey's has grown its net income by 19% annually over the last decade, Domino's Pizza has only grown its profits by 14% over the same time, yet trades at 23 times CFO. Before you buy stock in Casey's General Stores, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Casey's General Stores wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,871!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $875,479!* Now, it's worth noting Stock Advisor's total average return is 998% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Josh Kohn-Lindquist has positions in Casey's General Stores. The Motley Fool has positions in and recommends Domino's Pizza. The Motley Fool recommends Casey's General Stores. The Motley Fool has a disclosure policy. Why Casey's General Stores Stock Skyrocketed This Week was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
KBW Announces Index Rebalancing for Second-Quarter 2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE: SF), announces the upcoming index rebalancing for the second quarter of 2025. This quarter, there are constituent changes within one of our indexes: KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY). These changes will be effective prior to the opening of business on Monday, June 23, 2025. As part of this rebalancing, below are the component-level changes across impacted indices: KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX; ETF Ticker: KBWY) Drop (1): SITE Centers Corp. (NYSE: SITC) Several of the KBW Nasdaq indexes have tradable exchange‐traded funds licensed: KBW Nasdaq Bank Index (Index Ticker: BKXSM, ETF Ticker: KBWBSM); KBW Nasdaq Capital Markets Index (Index Ticker: KSXSM); KBW Nasdaq Insurance Index (Index Ticker: KIXSM); KBW Nasdaq Regional Banking Index (Index Ticker: KRXSM, ETF Ticker: KBWRSM); KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDXSM, ETF Ticker: KBWDSM); KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYXSM, ETF Ticker: KBWYSM); KBW Nasdaq Property and Casualty Insurance Index (Index Ticker: KPXSM, ETF Ticker: KBWPSM); KBW Nasdaq Global Bank Index (Index Ticker: GBKXSM); KBW Nasdaq Financial Technology Index (Index Ticker: KFTXSM, ETF Ticker: Not all of the listed securities may be suitable for retail investors; in addition, not all of the listed securities may be available to U.S. investors. European investors interested in FTEK LN can contact Invesco at U.S. investors cannot buy or hold FTEK LN. An investor cannot invest directly in an index. About KBW KBW (Keefe, Bruyette & Woods, Inc., operating in the U.S., and Stifel Nicolaus Europe Limited, also trading as Keefe, Bruyette & Woods Europe, operating in Europe) is a Stifel company. Over the years, KBW has established itself as a leading independent authority in the banking, insurance, brokerage, asset management, mortgage banking and specialty finance sectors. Founded in 1962, the firm maintains industry‐leading positions in the areas of research, corporate finance, mergers and acquisitions as well as sales and trading in equities securities of financial services companies. Media Contact Neil Shapiro, (212) 271-3447shapiron@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Sombre Fundamentals Suggest General Mills Stock (GIS) is Stuck in a Value Trap
Not so long ago, General Mills (GIS) stock was synonymous with safety, defensiveness, and stability. The company consistently delivered results in line with market expectations, rewarding shareholders with a generous and growing dividend. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The snacking category, once an exception among packaged food groups, seemed immune to changing eating habits and the rise of private-label brands. But things have taken a turn for the worse. Cereal and snack bar consumption has declined sharply due to growing structural headwinds, resulting in a contraction of General Mills' business. What remains solid, however, is the company's ability to generate value for shareholders above its cost of capital, which in theory still makes General Mills a defensive stock. Valuations at current levels also look attractive, offering some margin of safety. The problem is that the sustainability of these strengths is in question. When secular headwinds are at play, it doesn't matter much if fundamentals suggest a cushion or if valuations appear cheap—the stock is likely to continue drifting downward over time. That said, I see this as a potential value trap for investors hoping to be heroes with General Mills stock. For that reason, I hold a neutral view on GIS. U.S. consumers have been gradually changing their eating habits—and that's not just an opinion, it's a fact. The packaged foods sector has seen a decline in demand for snacks in recent years. A big part of this comes from the rapid rise in GLP-1 weight loss drugs and a new generation that's increasingly avoiding 'bad foods' in favor of a healthier lifestyle. Recent 2024 data shows that around 12% of American adults report having used a GLP-1 drug, with 6% currently using one. Some studies suggest that GLP-1 users significantly reduce their grocery store purchases by 6%, with a 11% drop in snack sales in the six months following adoption. This shift is already reflected in the financial results of packaged food companies, such as General Mills. Over the past three years, General Mills' revenue has grown at a CAGR of just 1.8%. While operating margins improved at a 4.9% compound annual growth rate (CAGR), free cash flow declined at an 8.7% CAGR, which is a concerning trend. In addition to these broad changes in consumer behavior, General Mills has been facing weak U.S. consumption trends due to market share losses in key categories, particularly to private-label brands from retailers such as Costco (COST) and Walmart (WMT). In its most recent earnings report, net sales totaled $4.8 billion, a 5% decline year over year, and fell short of analyst expectations. North American retail sales declined 7%, with a 6% drop in sales volume. Alongside softer demand, temporary pressures also played a role, including lower volumes in snacks and dry pet food. The pet segment declined 3% year over year, while international sales fell 4%, primarily due to foreign exchange headwinds and weaker results in key markets such as China and Brazil. As a result, General Mills revised its guidance for fiscal year 2025. The company now expects organic net sales to decline between 1.5% and 2%, compared to a previous forecast of flat to slightly positive growth (up to 1%). While General Mills' stock performance may appear underwhelming—hovering near the same levels it traded at over a decade ago—there are still compelling elements to its investment case. Despite a growth narrative that appears not just stalled but potentially in decline, the company continues to deliver strong returns on invested capital (ROIC). Over the past twelve months, General Mills generated $2.93 billion in NOPAT against $22.9 billion in invested capital, resulting in an ROIC of 12.8%. That figure aligns well with industry peers like Nestlé (NSRGY), Mondelez (MDLZ), and Kellogg's (KLG), and it comfortably exceeds the company's estimated cost of capital, highlighting efficient capital deployment even in a slow-growth environment. Assuming a cost of equity of 7.5% (given GIS's low beta and 10-year Treasury yields around 4.5%), and a 30% debt weighting, General Mills' weighted average cost of capital (WACC) would land around 6.8%. In other words, despite the recent headwinds, the company continues to create value for shareholders and allocate capital efficiently. That shows up in its dividend policy as well. General Mills currently offers a dividend yield of 4.4%, which is almost on par with the risk-free rate, all while maintaining a payout ratio of just 53%. Beyond General Mills' ability to generate returns above its cost of capital, the stock also appears attractively priced based on valuation. One particularly useful—and often underappreciated—metric for evaluating mature, capital-intensive companies like those in the consumer packaged goods sector is earnings yield, calculated as operating income divided by enterprise value. Over the past twelve months, General Mills reported $3.6 billion in operating income (EBIT) against an enterprise value of $43.5 billion, resulting in an earnings yield of 8.4%. Compared to a weighted average cost of capital (WACC) of 6.8%, this positive spread suggests the company is generating real value for shareholders—a potentially encouraging sign for long-term investors. However, the reliability of earnings yield as a valuation signal rests on the assumption that earnings will remain stable or improve. In General Mills' case, that assumption is under strain. The company recently lowered its fiscal 2025 guidance, now forecasting a 7% to 8% decline in adjusted operating profit, nearly twice the size of its earlier projections. In short, while the current valuation offers a degree of margin of safety, the growing uncertainty around future profitability raises meaningful concerns and tempers a more bullish outlook. Analyst sentiment on General Mills (GIS) remains mixed. Of the 13 analysts covering the stock, only one holds a bullish rating, ten are neutral, and one is bearish. The consensus stock price target for GIS stock is $57.67, representing an upside of approximately 6.7% over the coming year. General Mills checks many of the boxes for a classic value investment, consistently generating returns above its cost of capital while trading at what appears to be an attractive valuation. However, the company is contending with mounting structural headwinds—including evolving consumer eating habits, the rise of GLP-1 drugs, shifting retail dynamics, and increased competition from private-label brands. These challenges cast doubt on the long-term sustainability of its value creation, despite current metrics remaining solid. Given these concerns, General Mills currently leans more toward a value trap than a compelling value opportunity. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
